GNAI1

Chr 7AD

G protein subunit alpha i1

Also known as: Gi, HG1B, NEDHISB

The protein is the alpha subunit of an inhibitory G protein complex that responds to beta-adrenergic signals by inhibiting adenylate cyclase. Heterozygous mutations cause a neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities through an autosomal dominant inheritance pattern. The high pLI score (0.91) and low LOEUF score (0.38) indicate the gene is highly intolerant to loss-of-function variants, suggesting haploinsufficiency as the likely pathogenic mechanism.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 0.381 OMIM phenotype
Clinical SummaryGNAI1
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.91). One damaged copy is likely sufficient to cause disease.
📖
GeneReview available — GNAI1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.38LOEUF
pLI 0.911
Z-score 3.32
OE 0.12 (0.050.38)
Highly constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
2.63Z-score
OE missense 0.45 (0.380.54)
83 obs / 183.1 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.12 (0.050.38)
00.351.4
Missense OE0.45 (0.380.54)
00.61.4
Synonymous OE1.34
01.21.6
LoF obs/exp: 2 / 16.6Missense obs/exp: 83 / 183.1Syn Z: -2.05
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateGNAI1-related neurodevelopmental disorder with hypotonia, impaired speech, and behavioural abnormalitiesOTHERAD
DN
0.4983th %ile
GOF
0.6639th %ile
LOF
0.48top 25%

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and loss-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
LOFLOEUF 0.38

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

GNAI1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →